TOMI Appoints Three New Independent Members to Its Board of Directors
Feb 01, 2016 21:05 pm UTC| Business
BEVERLY HILLS, Calif., Feb. 01, 2016 -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, announced it has appointed three new independent...
WageWorks Schedules Fourth Quarter and Full Year 2015 Financial Results Conference Call
Feb 01, 2016 21:05 pm UTC| Business
SAN MATEO, Calif., Feb. 01, 2016 -- WageWorks, Inc. (NYSE: WAGE), a leader in administering Consumer-Directed Benefits, today announced that it will release financial results for its fourth quarter and full year 2015...
LDR Holding Corporation Announces Fourth Quarter 2015 Conference Call
Feb 01, 2016 21:05 pm UTC| Business
AUSTIN, Texas, Feb. 01, 2016 -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients...
Five Prime Therapeutics Announces Key Executive Appointments
Feb 01, 2016 21:05 pm UTC| Business
Kevin Baker, Ph.D., appointed as Senior Vice President of Development SciencesRobert Sikorski, M.D., Ph.D., promoted to Senior Vice President of Global Clinical Development SOUTH SAN FRANCISCO, Calif., Feb. 01, 2016 --...
Curis to Present at the BIO CEO & Investor Conference
Feb 01, 2016 21:05 pm UTC| Business
LEXINGTON, Mass., Feb. 01, 2016 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced...
Feb 01, 2016 21:05 pm UTC| Business
MCLEAN, Va., Feb. 01, 2016 -- Gladstone Commercial Corporation (NASDAQ:GOOD) (the “Company” or “Gladstone Commercial”) reported today that it successfully exited its $5.9 million second mortgage development loan, which...
Prothena to Participate in BIO CEO & Investor and Leerink Partners Healthcare Conferences
Feb 01, 2016 21:05 pm UTC| Business
DUBLIN, Ireland, Feb. 01, 2016 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today...